Tap a claim on the ring to put it at the centre.
← The pharmaceutical productivity crisis has no single villain: nearly…
17 connected korrents · 15 moments from 8 Mar 2012 to 17 Sept 2026.
Everything filed under innovation
innovation
Everything filed under ambition
ambition
Everything filed under creativity
creativity
Everything filed under LLMs
LLMs
Everything filed under AI and science
AI and science Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Same subject Read this korrent: The pharmaceutical productivity crisis has no single villain: nearly every part of discovery and development got gradually harder and more expensive at once. The pharmaceutical productivity crisis has no single villain: nearly every part of discovery and development got gradually harder and more expensive at once. Last stated 3 years ago
23 Dec 2023
AT
Alex Telford — holds since 2023-12-23 — tap for who they are
Same subject: Pharmaceutical R&D productivity has fallen for decades: far more money spent per drug, with no matching improvement in the odds a candidate reaches the market. — tap to centre the map on it Pharmaceutical R&D productivity has fallen for decades: far more money spent per drug, with no matching improvement in the odds a candidate reaches the market. Last stated 3 months ago
21 Jul 2026
AT
Alex Telford — holds since 2023-12-23 — tap for who they are
RT
Ruxandra Teslo — holds since 2026-07-21 — tap for who they are
Same subject: Drug discovery has become less efficient over time despite continued technological progress. — tap to centre the map on it Drug discovery has become less efficient over time despite continued technological progress. Last stated 9 months ago
18 Jan 2026
EH
Elliot Hershberg — holds since 2026-01-18 — tap for who they are
Same subject: New technologies can meaningfully improve R&D productivity in drug development. — tap to centre the map on it New technologies can meaningfully improve R&D productivity in drug development. Last stated 6 months ago
12 Apr 2026
EH
Elliot Hershberg — holds since 2026-04-12 — tap for who they are
Same subject: When pharmaceutical companies act as top-down gatekeepers for which therapeutic ideas get pursued, promising innovations from startups can be overlooked. — tap to centre the map on it When pharmaceutical companies act as top-down gatekeepers for which therapeutic ideas get pursued, promising innovations from startups can be overlooked. Last stated 6 months ago
12 Apr 2026
EH
Elliot Hershberg — holds since 2026-04-12 — tap for who they are
Same subject: Every new drug has to beat the cheap generics that came before it, and that competition with our own back catalogue is why drug discovery gets harder over time. — tap to centre the map on it Every new drug has to beat the cheap generics that came before it, and that competition with our own back catalogue is why drug discovery gets harder over time. Last stated 15 years ago
8 Mar 2012
DL
Derek Lowe — holds since 2012-03-08 — tap for who they are
Same subject: Drug research is heading, at speed, for a world in which fewer and fewer useful medicines are discovered while more and more people want them. — tap to centre the map on it Drug research is heading, at speed, for a world in which fewer and fewer useful medicines are discovered while more and more people want them. Last stated 15 years ago
8 Mar 2012
DL
Derek Lowe — holds since 2012-03-08 — tap for who they are
Same subject: A computational discovery platform does not make a biotech fast, because the thousand other steps of drug development are still the bottleneck. — tap to centre the map on it A computational discovery platform does not make a biotech fast, because the thousand other steps of drug development are still the bottleneck. Last stated 2 years ago
17 Sept 2024
AT
Alex Telford — holds since 2024-09-17 — tap for who they are
Same subject: The pace of medical innovation can be sped up or slowed down by policy, funding and institutional choices. — tap to centre the map on it The pace of medical innovation can be sped up or slowed down by policy, funding and institutional choices. Last stated 10 months ago
28 Dec 2025
SD
Saloni Dattani — holds since 2025-12-28 — tap for who they are
Same subject: A contest between five paid firms is not the way to get good creative work. — tap to centre the map on it A contest between five paid firms is not the way to get good creative work. Last stated 2 months ago
14 Aug 2026
SK
Susan Kare — holds since 2026-08-14 — tap for who they are
Same subject: A feeling of responsibility is probably the greatest inhibitor of creativity; great ideas came from people not paid to have them — tap to centre the map on it A feeling of responsibility is probably the greatest inhibitor of creativity; great ideas came from people not paid to have them
IA
Isaac Asimov — holds since c. 1959 — tap for who they are
Same subject: A free-wheeling, anarchic neural organization may be the secret of human creativity, at the price of susceptibility to mental illness — tap to centre the map on it A free-wheeling, anarchic neural organization may be the secret of human creativity, at the price of susceptibility to mental illness Last stated 14 years ago
8 Jan 2013
DD
Daniel Dennett — holds since 2013-01-08 — tap for who they are
Same subject: A badly written AI outbound email is evidence of a bad vendor, not of a limit of AI. — tap to centre the map on it A badly written AI outbound email is evidence of a bad vendor, not of a limit of AI. Last stated 10 months ago
1 Jan 2026
JL
Jason Lemkin — holds since 2026-01-01 — tap for who they are
Same subject: A bigger context window does not give you a smarter model; the intelligence of the model is what decides how much of that window it can actually attend to. — tap to centre the map on it A bigger context window does not give you a smarter model; the intelligence of the model is what decides how much of that window it can actually attend to. Last stated 3 months ago
15 Jul 2026
DH
Dex Horthy — holds since 2026-07-15 — tap for who they are
Same subject: A body of publications is easy for AI models to consume via pretraining corpora but cumbersome for most humans due to CAPTCHAs, accounts, and paywalls. — tap to centre the map on it A body of publications is easy for AI models to consume via pretraining corpora but cumbersome for most humans due to CAPTCHAs, accounts, and paywalls. Last stated a month ago
17 Sept 2026
PC
Patrick Collison — holds since 2026-09-17 — tap for who they are
Same subject: "If you're not growing, you're dying" is truer of the person than of the company. — tap to centre the map on it "If you're not growing, you're dying" is truer of the person than of the company. Last stated 9 months ago
25 Jan 2026
JC
Jason Cohen — holds since 2026-01-25 — tap for who they are
Same subject: A common-sense utopia is much closer to the present day than it is to the best futures actually available to us. — tap to centre the map on it A common-sense utopia is much closer to the present day than it is to the best futures actually available to us. Last stated a year ago
3 Aug 2025
WM
William MacAskill — holds since 2025-08-03 — tap for who they are
Same subject: A company can run at a fast pace sustainably without constant overwork or undue stress — tap to centre the map on it A company can run at a fast pace sustainably without constant overwork or undue stress Last stated 4 years ago
4 Nov 2022
DH
David Heinemeier Hansson — holds since 2022-11-04 — tap for who they are
At the centre
The pharmaceutical productivity crisis has no single villain: nearly every part of discovery and development got gradually harder and more expensive at once.
Holds Read this korrent →
Pharmaceutical R&D productivity has fallen for decades: far more money spent per drug, with no matching improvement in the odds a candidate reaches the market.
Holds
Drug discovery has become less efficient over time despite continued technological progress.
Holds
New technologies can meaningfully improve R&D productivity in drug development.
Holds
When pharmaceutical companies act as top-down gatekeepers for which therapeutic ideas get pursued, promising innovations from startups can be overlooked.
Holds
Every new drug has to beat the cheap generics that came before it, and that competition with our own back catalogue is why drug discovery gets harder over time.
Holds
Drug research is heading, at speed, for a world in which fewer and fewer useful medicines are discovered while more and more people want them.
Holds
A computational discovery platform does not make a biotech fast, because the thousand other steps of drug development are still the bottleneck.
Holds
The pace of medical innovation can be sped up or slowed down by policy, funding and institutional choices.
Holds
A contest between five paid firms is not the way to get good creative work.
Holds
A feeling of responsibility is probably the greatest inhibitor of creativity; great ideas came from people not paid to have them
Last stated c. 1959
Holds
A free-wheeling, anarchic neural organization may be the secret of human creativity, at the price of susceptibility to mental illness
Holds
A badly written AI outbound email is evidence of a bad vendor, not of a limit of AI.
Holds
A bigger context window does not give you a smarter model; the intelligence of the model is what decides how much of that window it can actually attend to.
Holds
A body of publications is easy for AI models to consume via pretraining corpora but cumbersome for most humans due to CAPTCHAs, accounts, and paywalls.
Holds
"If you're not growing, you're dying" is truer of the person than of the company.
Holds
A common-sense utopia is much closer to the present day than it is to the best futures actually available to us.
Holds
A company can run at a fast pace sustainably without constant overwork or undue stress
Holds